Medical cannabis use in Canadians with multiple sclerosis.

[1]  R. Tsuyuki,et al.  Measuring the Effects of Nurse-Practitioner (NP)-Led Care on Depression and Anxiety Levels in People with Multiple Sclerosis:  A Study Protocol for a Randomized Controlled Trial , 2021 .

[2]  A. Oturai,et al.  Illegal cannabis use is common among Danes with multiple sclerosis. , 2019, Multiple sclerosis and related disorders.

[3]  G. Giovannoni,et al.  Multiple sclerosis – a review , 2018, European journal of neurology.

[4]  Raed Alroughani,et al.  Multiple Sclerosis , 2018, Seminars in Neurology.

[5]  Chelsea Cox.  The Canadian Cannabis Act legalizes and regulates recreational cannabis use in 2018. , 2018, Health policy.

[6]  L. Degenhardt,et al.  The Use of Cannabis and Cannabinoids in Treating Symptoms of Multiple Sclerosis: a Systematic Review of Reviews , 2018, Current Neurology and Neuroscience Reports.

[7]  Suzy L. Wong,et al.  Multiple sclerosis: Prevalence and impact. , 2018, Health reports.

[8]  R. Tandon,et al.  Pros and Cons of Medical Cannabis use by People with Chronic Brain Disorders , 2017, Current neuropharmacology.

[9]  A. Feinstein,et al.  Cannabis and cognitive functioning in multiple sclerosis: The role of gender , 2017, Multiple sclerosis journal - experimental, translational and clinical.

[10]  G. Ko,et al.  Medical cannabis – the Canadian perspective , 2016, Journal of pain research.

[11]  A. Feinstein,et al.  What to make of cannabis and cognition in MS: In search of clarity amidst the haze , 2015, Multiple sclerosis.

[12]  J. Bronstein,et al.  Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders , 2014, Neurology.

[13]  Robert W Motl,et al.  Validation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosis , 2013, BMC Neurology.

[14]  Ethan B. Russo.  Taming THC: potential cannabis synergy and phytocannabinoid‐terpenoid entourage effects , 2011, British journal of pharmacology.

[15]  M. Tierney,et al.  Effects of cannabis on cognitive function in patients with multiple sclerosis , 2011, Neurology.

[16]  P. Sørensen,et al.  The changing demographic pattern of multiple sclerosis epidemiology , 2010, The Lancet Neurology.

[17]  T. J. Murray,et al.  Patterns of cannabis use among patients with multiple sclerosis , 2004, Neurology.

[18]  R. Stebbins,et al.  Cannabis Use as Described by People with Multiple Sclerosis , 2003, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[19]  G. W. Ellison,et al.  A health-related quality of life measure for multiple sclerosis , 1995, Quality of Life Research.

[20]  C. Bever,et al.  Summary of evidence-based guideline: Complementary and alternative medicine in multiple sclerosis , 2014, Neurology.